Bélec L, Tevi-Benissan C, Bianchi A, et al.
Laboratoire de virologie, Hôpital Broussais, Paris, France. Unité INSERM U430 and Université Pierre et Marie Curie (Paris VI), H opital Broussais. email@example.com
SourceJ Antimicrob Chemother 2000 Nov; 46(5)
Kinetics of inactivation by the detergent spermicide benzalkonium chloride (BZK) of Chlamydia trachomatis and of a panel of DNA viruses [herpes simplex virus hominis type 2 (HSV-2), cytomegalovirus (CMV), adenovirus (ADV) and BK virus (BKV)] and RNA [respiratory syncytial virus (RSV) and enterovirus (ENV)] were established in accordance with a standardized in vitro protocol. After a 5 min incubation, inactivation of >95% of HSV-2 and CMV was obtained at a concentration of 0.0025% (w/v) (25 Ig/L); concentrations as low as 0.0005%, 0.0050% and 0.0125%, induced a 3.0 log10 reduction in infectivity of HSV-2 and CMV, RSV and ADV, respectively. After a 60 min incubation, concentrations of 0.0125% and 0.050% provided a 3.0 log10 reduction in infectivity of ENV and BKV, respectively. These features indicate that sensitivity to BZK was very high (HSV-2 and CMV) or high (RSV) for enveloped viruses, intermediate (ADV) or low (ENV and BKV) for non-enveloped viruses. Furthermore, BZK had marked antichlamydial activity, showing >99% killing after only a 1 min incubation at a concentration of 0.00125%. BZK demonstrates potent in vitro activity against the majority of microorganisms causing sexually transmitted infectious diseases, including those acting as major genital cofactors of human immunodeficiency virus transmission. These attributes qualify BZK as a particularly attractive candidate for microbicide development.
MeshAdenoviridaeAnti-Infective Agents, LocalBK VirusBenzalkonium CompoundsChlamydia trachomatisCytomegalovirusDNA VirusesEnterovirusHerpesvirus 2, HumanHumansRNA VirusesRespiratory Syncytial VirusesSexually Transmitted Diseases, ViralSpermatocidal Agents
Journal Article Research Support, Non-U.S. Gov't